Natural plant mucilage has gained importance over synthetic ones because of low toxicity, low cost and good availability. The objective of the study was to search for a cheap and effective natural raw material that can serve as an alternative suspending agent in the formulation of acetaminophen suspension.
Background: Artemisinin based combination therapies (ACTs) typified by dihydroartemisinin-piperaquine phosphate is one of the first line drugs used in the treatment of Plasmodium falciparum malaria. However, the emergence of drug resistance to ACTs show the necessity to develop novel sustained release treatment in order to ensure maximum bioavailability. Objectives: To formulate dihydroartemisinin (DHA)-piperaquine phosphate (PQ) sustained release tablets based on solidified reverse micellar solutions (SRMS). Methods: The SRMS was prepared by fusion using varying ratios of Phospholipon® 90H and Softisan® 154 and characterised. The tablets were prepared by using an in-house made and validated mould. The formulations were tested for uniformity of weight, hardness, friability, softening time, erosion time and in vitro-in vivo dissolution rate. Anti malarial properties were studied by modified Peter’s 4-days suppressive test in mice. One-way analysis of variance (ANOVA) was used in analysis of results. Results: Smooth caplets, with average weight of 1300 ± 0.06 to 1312 ± 0.11 mg, drug content of 61 mg for DHA and t 450 mg for PQ. Tablets hardness ranged from 7.1 to 9.0 Kgf and softening time of 29.50 ± 1.90 min. Erosion time of 62.00 ± 2.58 to 152.00 ± 1.89 min were obtained for tablets formulated with Poloxamer 188 (Batches R2, S2 and T2) which significantly reduced the softening and erosion time (p < 0.05). In vitro release showed that optimized formulation had maximum release at 12 h. Formulations exhibited significantly higher parasitaemia clearance and in vivo absorption compared to marketed formulations at day 7 (p < 0.05). Conclusion: DHA-PQ tablets based on SRMS is much easier and relatively cheaper to produce than compressed tablets. They also showed exceptionally better treatment of malaria owing to their sustained release properties and improved bioavailability and is recommended to Pharmaceutical companies for further studies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.